This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of selegiline
PDMED_SELEGILINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1702 |
4. Check minimum number of events
Min. number of events
3
|
1702 |
5. Include endpointsNone |
1702 |
6. Filter based on genotype QC (FinnGen only) |
1702 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of selegiline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1702 | 713 | 989 |
| Unadjusted period prevalence (%) | 0.36 | 0.24 | 0.44 |
| Median age at first event (years) | 64.70 | 63.39 | 65.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1502
- Matched controls
- 15020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
193
Kela drug reimbursment
Rasagiline
273.7
323.0
387
19
N04BC04
ATC
ropinirole; oral
174.2
323.0
524
46
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
351.5
323.0
1285
249
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
1101.6
323.0
1396
180
N87
ICPC
Parkinsonism
122.2
323.0
537
68
N04BC05
ATC
pramipexole; oral
30.1
323.0
837
603
G20
ICD-10 Finland
Parkinson disease
739.5
323.0
1377
224
N04BD01
ATC
selegiline; oral
+∞
323.0
1502
25
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
355.7
323.0
600
28
N04BD02
ATC
rasagiline; oral
254.7
323.0
448
25
N04BX02
ATC
entacapone; oral
789.1
274.2
262
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
125.1
219.4
233
22
N04BC09
ATC
rotigotine; transdermal
143.9
190.5
200
16
N04BB01
ATC
amantadine; oral
36.2
153.4
199
63
R25.1
ICD-10 Finland
Tremor, unspecified
13.9
127.9
229
192
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
272.3
124.0
125
5
N03AE01
ATC
clonazepam; systemic
7.9
105.8
260
387
N06DA03
ATC
rivastigmine; oral, transdermal
8.0
104.6
254
371
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
25.8
99.7
141
60
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
209.4
95.6
98
5
N05AH04
ATC
quetiapine; oral
4.5
94.5
389
1080
N04BC02
ATC
pergolide; oral
402.4
77.5
77
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
55.5
66.7
79
15
N04AA02
ATC
biperiden; systemic
12.3
65.1
121
106
G04BD12
ATC
mirabegron; oral
3.7
62.4
308
970
H02AA02
ATC
fludrocortisone; oral
21.4
58.5
87
43
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
127.0
57.2
61
5
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
65.6
54.7
63
10
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
69.3
52.5
60
9
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
51.6
214
571
G02CB01
ATC
bromocriptine; systemic
17.0
50.5
81
50
SPAT1229
SPAT
Assessment of need for aid
3.7
50.5
244
745
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
50.4
569
3012
XA800
NOMESCO Finland
Neuropsychological investigation
6.7
46.0
122
195
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
65.9
44.4
51
8
C07AA05
ATC
propranolol; systemic
2.8
43.8
341
1446
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.0
43.6
187
511
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
32.8
43.5
57
18
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
40.5
372
1726
N19
ICPC
Speech disorder
13.3
39.6
70
55
I95.1
ICD-10 Finland
Orthostatic hypotension
4.9
39.5
135
294
R1250
NOMESCO Finland
Evaluation of functional capability
7.8
38.8
92
125
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
10.7
35.8
70
68
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
19.6
35.0
53
28
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.6
34.8
127
296
AA1AD
NOMESCO Finland
CT of head and brain
2.1
32.8
471
2667
A06AD11
ATC
lactulose; oral
2.3
32.0
345
1711
SPAT1216
SPAT
Assessment of functional ability
2.3
30.0
330
1648
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.7
29.1
134
386
XF606
NOMESCO Finland
Ortostatic test
11.6
28.5
53
47
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.8
27.9
81
146
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.3
27.9
151
495
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
26.8
152
514
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.1
25.5
149
513
N04BC01
ATC
bromocriptine; oral
254.1
24.7
25
*
L28
ICPC
Limited function/disability (L)
2.1
24.2
313
1662
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
22.9
297
1577
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.4
22.6
114
354
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
22.0
152
585
R53
ICD-10 Finland
Malaise and fatigue
2.0
21.9
345
1976
SPAT1234
SPAT
Support of social functional capacity
3.1
21.6
124
423
R47.1
ICD-10 Finland
Dysarthria and anarthria
8.3
20.8
46
57
A28
ICPC
Limited function/disability NOS
2.0
20.6
311
1745
N03AX12
ATC
gabapentin; oral
2.1
20.4
256
1330
D21
ICPC
Swallowing problem
6.3
20.3
54
88
N86
ICPC
Multiple sclerosis
16.3
20.1
32
20
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
20.1
502
3347
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.2
19.9
77
191
N04BX01
ATC
tolcapone; oral
+∞
19.8
19
*
N06AX11
ATC
mirtazapine; oral
1.8
19.2
454
2969
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
20.3
19.1
28
14
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
55.7
18.9
22
*
N05BA04
ATC
oxazepam; oral
1.8
18.9
376
2319
U04
ICPC
Incontinence urine
3.1
18.9
107
360
N04BC07
ATC
apomorphine; parenteral
+∞
18.8
18
*
M48.0
ICD-10 Finland
Spinal stenosis
2.1
18.7
244
1288
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
18.2
62
136
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.3
18.1
48
78
R4130
NOMESCO Finland
Speech therapy
4.4
17.5
64
151
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
7.4
17.3
41
57
R60.0
ICD-10 Finland
Localized oedema
2.1
17.3
212
1088
G35
ICD-10 Finland
Multiple sclerosis
8.6
17.2
37
44
N28
ICPC
Limited function/disability (N)
5.3
17.0
52
101
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
16.9
138
581
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
171.8
16.5
17
*
N29
ICPC
Neurological sympt/complt other
4.8
16.5
55
118
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.2
15.7
48
94
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
15.6
146
660
130
Kela drug reimbursment
Malignant tumour
0.3
15.1
23
879
N06BA07
ATC
modafinil; oral
57.2
14.8
17
*
F0232, G20
ICD-10 Finland
NA
+∞
14.6
14
*
N04BX04
ATC
opicapone; oral
151.4
14.5
15
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
14.2
293
1813
R35
ICD-10 Finland
Polyuria
2.3
14.0
128
574
S72.0
ICD-10 Finland
Fracture of neck of femur
2.7
13.9
98
383
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
13.8
233
1347
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
13.6
60
169
AA5QN
NOMESCO Finland
NA
75.8
13.6
15
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
13.4
102
417
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
11.6
13.3
24
21
G04BD09
ATC
trospium; oral
3.3
12.9
65
204
G25.2
ICD-10 Finland
Other specified forms of tremor
9.1
12.7
26
29
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
32.3
12.6
16
5
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
12.5
657
8047
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
12.4
72
249
C01CA01
ATC
etilefrine; systemic
6.9
12.4
30
44
G90.3
ICD-10 Finland
Multi-system degeneration
37.9
12.2
15
*
G25.0
ICD-10 Finland
Essential tremor
3.4
12.1
57
170
S01.0
ICD-10 Finland
Open wound of scalp
2.2
11.9
131
638
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
11.9
140
703
G04BD04
ATC
oxybutynin; oral, transdermal
2.3
11.8
107
479
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
11.8
150
779
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.4
11.8
42
98
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.6
11.7
33
60
N30.0
ICD-10 Finland
Acute cystitis
1.8
11.3
196
1142
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
11.3
109
1965
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
5.7
11.2
31
55
R13
ICD-10 Finland
Dysphagia
2.2
11.2
110
512
N06AB10
ATC
escitalopram; oral
1.8
11.0
214
1289
W19
ICD-10 Finland
Unspecified fall
2.0
10.8
144
760
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
10.8
91
393
N04AA01
ATC
trihexyphenidyl; oral
28.2
10.7
14
5
K59.09
ICD-10 Finland
Constipation, unspecified
2.1
10.4
116
570
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
10.3
410
2982
A04
ICPC
Weakness/tiredness general
1.8
10.2
180
1051
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.3
10.2
26
42
R1260
NOMESCO Finland
Evaluation of communicative skills
3.4
10.1
47
140
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.8
10.0
64
238
J01EA01
ATC
trimethoprim; systemic
1.5
9.9
354
2514
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
9.8
211
1309
M54.5
ICD-10 Finland
Low back pain
1.5
9.8
404
2958
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.8
621
4959
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
9.6
*
348
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.8
9.6
61
226
H50.52
ICD-10 Finland
Exophoria
6.7
9.4
23
35
34200
ICD-8 Finland
Paralysis agitans, Parkinsonismus
100.6
9.4
10
*
F0230, G20
ICD-10 Finland
NA
+∞
9.4
9
*
F0234, G20
ICD-10 Finland
NA
+∞
9.4
9
*
N99
ICPC
Neurological disease other
4.5
9.4
32
73
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.9
9.3
29
60
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.5
9.2
70
287
H02AB02
ATC
dexamethasone; systemic
0.4
9.2
36
887
N05AH02
ATC
clozapine; systemic
6.7
9.1
22
33
N06AX03
ATC
mianserin; oral
2.3
9.1
84
381
K59.0
ICD-10 Finland
Constipation
2.1
9.1
102
503
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.1
9.0
47
154
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.2
8.9
46
149
G21.8
ICD-10 Finland
Other secondary parkinsonism
24.2
8.9
12
5
R44.1
ICD-10 Finland
Visual hallucinations
8.0
8.9
19
24
M03BX01
ATC
baclofen; systemic
4.0
8.9
34
87
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
6.6
8.7
21
32
M41.5
ICD-10 Finland
Other secondary scoliosis
20.1
8.5
12
6
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
6.0
8.5
22
37
M41.4
ICD-10 Finland
Neuromuscular scoliosis
90.5
8.4
9
*
C10AA05
ATC
atorvastatin; oral
0.7
8.4
370
4786
214
Kela drug reimbursment
Severe and chronic narcolepsy
+∞
8.3
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
8.3
215
1407
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
8.3
99
504
R23
ICPC
Voice symptom/complaint
3.6
8.3
36
103
L03
ICPC
Low back symptom/complaint
1.5
8.2
296
2094
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
8.2
211
1376
K56.2
ICD-10 Finland
Volvulus
6.1
8.2
21
35
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
8.1
60
1178
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
33.5
8.1
10
*
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
33.5
8.1
10
*
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
17.3
8.1
12
7
N06AB04
ATC
citalopram; systemic
1.5
8.0
282
1985
N30.9
ICD-10 Finland
Cystitis, unspecified
2.1
8.0
88
434
Z75.5
ICD-10 Finland
Holiday relief care
3.9
8.0
31
81
G04BD08
ATC
solifenacin; oral
1.9
7.9
114
620
RF120
NOMESCO Finland
NA
4.5
7.9
26
58
N06BA04
ATC
methylphenidate; oral
8.5
7.8
16
19
R32
ICD-10 Finland
Unspecified urinary incontinence
2.8
7.8
47
171
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
7.6
137
804
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
7.6
128
737
WX290
NOMESCO Finland
Other blockade of nerve
1.4
7.6
424
3270
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
25.1
7.6
10
*
SPAT1254
SPAT
Administration of medicine
1.6
7.5
216
1449
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
13.4
7.4
12
9
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
10.9
7.3
13
12
N04C02
ATC
NA
+∞
7.3
7
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
7.3
7
*
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
7.3
7
*
S70.0
ICD-10 Finland
Contusion of hip
2.3
7.2
61
268
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
7.1
63
283
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.1
224
1534
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.1
7.1
21
42
G04BD11
ATC
fesoterodine; oral
2.3
7.0
59
258
S06.0
ICD-10 Finland
Concussion
1.8
7.0
126
743
H50.31
ICD-10 Finland
Intermittent exotropia
6.4
6.9
17
27
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.0
6.9
86
445
C08CA01
ATC
amlodipine; oral
0.7
6.8
353
4481
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.0
6.7
36
122
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.4
6.7
27
655
SPAT1167
SPAT
Insertion of urinary catheter
2.2
6.7
62
284
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
6.6
56
244
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
6.6
46
181
N08
ICPC
Abnormal involuntary movements
8.7
6.6
13
15
AA1AA
NOMESCO Finland
Head X-ray examination
4.8
6.5
20
42
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.5
274
1995
XKC03
NOMESCO Finland
Water cystometry
2.4
6.5
53
229
3339X
ICD-9 Finland
Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders
70.1
6.4
7
*
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
6.4
72
361
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.3
108
625
Z50.5
ICD-10 Finland
Speech therapy
3.7
6.3
25
68
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.1
6.3
31
100
TKC22
NOMESCO Finland
Catheterisation instruction
2.7
6.3
41
157
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
18.1
6.3
9
5
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.2
183
1232
359
Kela drug reimbursment
Mirabegroni
4.8
6.2
19
40
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.2
579
4825
L84
ICD-10 Finland
Corns and callosities
2.3
6.2
54
242
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
5.0
6.2
18
36
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
6.2
98
555
R55
ICD-10 Finland
Syncope and collapse
1.6
6.1
167
1105
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.4
6.1
47
198
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.1
275
2032
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.4
6.0
27
81
R44.3
ICD-10 Finland
Hallucinations, unspecified
6.7
6.0
14
21
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
6.0
160
1054
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
41
12.79
52.24
1.7
1.3
83.38
141.88
nmol/l
1.02
29
30
1099
12561
0.65
15.42
4.0
4.8
4.43
4.47
mmol/l
0.84
962
11380
1086
12439
0.65
15.33
4.0
4.7
1.46
1.44
mmol/l
0.95
942
11170
1140
12898
0.65
14.78
4.4
5.4
2.59
2.59
mmol/l
0.03
994
11604
1050
12052
0.66
14.20
3.6
4.2
1.12
1.28
mmol/l
17.06
903
10721
330
4778
0.62
13.66
3.8
4.0
5.33
8.91
mg/mmol
3.28
227
3030
595
4496
1.50
13.27
2.4
2.2
238.83
229.53
u/l
0.09
552
4189
34
84
4.11
12.59
2.9
2.4
—
—
—
0
0
313
4508
0.63
12.39
3.0
3.3
284.72
283.72
mg/l
0.00
212
2890
319
4573
0.63
12.37
2.9
3.2
8.02
7.31
mmol/l
2.17
264
3768
277
1860
1.58
10.31
8.0
8.2
—
—
—
0
0
1054
9130
1.41
10.14
6.5
4.9
6061.62
1953.83
e6/l
0.48
21
152
1099
12254
0.71
9.90
5.8
6.5
39.68
40.85
mmol/mol
4.25
967
11129
478
3648
1.43
9.47
1.7
1.6
18.22
20.37
nmol/l
2.68
416
3056
423
3188
1.43
8.90
1.9
1.8
1212.42
1173.91
nmol/l
0.37
312
2372
465
3601
1.40
8.31
4.9
4.4
0.00
0.00
estimate
0.69
150
1176
251
3488
0.67
7.72
1.4
1.6
1.16
1.34
mmol/l
4.24
197
2853
732
6203
1.32
6.98
2.2
2.1
85.27
93.09
pmol/l
6.25
459
3242
419
3283
1.37
6.77
1.7
1.7
394.23
13439462.74
pmol/l
1.75
337
2649
1173
12725
0.75
6.77
4.5
5.1
5.92
6.09
mmol/l
5.65
1001
11301
920
10290
0.77
6.50
21.7
20.6
13.71
13.89
%
2.78
893
10017
778
6721
1.29
6.17
4.6
6.0
1.21
1.21
mmol/l
0.46
682
6032
683
5803
1.30
6.16
4.8
4.1
38.74
58.09
ng/l
1.21
560
4460
748
6443
1.29
6.02
4.7
4.0
0.00
0.00
estimate
0.00
158
1237
151
1010
1.54
5.67
2.0
1.7
—
—
—
0
0
1280
13628
0.75
5.63
9.3
11.3
18.25
25.47
u/l
14.70
1167
13030
107
1652
0.62
5.30
2.9
4.1
42.85
22.31
ug/l
0.30
81
1389
360
2850
1.33
5.30
5.0
4.5
1.02
1.02
kg/l
0.74
58
427
581
4938
1.27
4.95
5.1
4.4
—
—
—
0
0
746
6535
1.25
4.88
4.8
4.0
0.00
0.01
estimate
1.08
158
1201
1334
14060
0.76
4.81
27.5
25.0
6.63
6.85
e9/l
3.18
1290
13552
1335
14061
0.77
4.70
27.6
25.1
130.77
133.50
g/l
9.42
1308
13763
1335
14058
0.77
4.66
27.4
24.9
4.34
4.41
e12/l
5.40
1289
13549
1335
14054
0.77
4.61
27.4
24.9
244.98
240.94
e9/l
1.49
1292
13603
734
6448
1.24
4.60
6.2
5.4
0.00
0.00
estimate
0.00
162
1236
1137
12175
0.80
4.34
17.2
16.1
81.28
73.97
ml/min/173m2
31.71
978
10106
1033
11172
0.81
4.31
19.1
18.4
38.18
38.65
%
0.64
559
6954
338
4115
0.78
4.12
2.5
3.1
28.84
34.55
u/l
2.41
311
3899
819
7343
1.22
4.06
4.8
6.9
1.21
1.21
mmol/l
0.43
669
6156
86
1311
0.64
4.05
1.3
1.3
—
—
—
0
0
342
2799
1.28
3.85
1.8
1.7
1.27
1.44
mg/l
0.64
271
2198
131
926
1.45
3.82
1.6
1.5
—
—
—
0
0
21
84
2.52
3.72
1.2
2.0
—
—
—
0
0
75
1151
0.64
3.66
1.5
1.7
1.48
1.61
%
0.63
64
953
318
2597
1.28
3.63
1.9
1.9
—
—
—
0
0
918
8387
1.21
3.56
4.4
4.9
6.41
6.87
mmol/l
14.47
878
7904
94
631
1.52
3.56
3.7
4.2
25.54
25.00
mmol/l
1.05
82
583
408
3453
1.24
3.41
2.5
2.5
—
—
—
0
0
140
1035
1.38
3.21
5.5
6.6
25.73
24.50
mmol/l
5.39
130
968
231
1846
1.29
3.13
4.3
6.8
5.27
5.09
kpa
2.48
219
1756
231
1847
1.29
3.12
4.3
6.8
12.19
11.82
kpa
0.45
218
1759
231
1853
1.29
3.04
4.3
6.8
1.84
1.11
mmol/l
2.40
188
1427
88
606
1.48
2.99
1.9
1.8
—
—
—
0
0
602
5358
1.19
2.95
3.7
3.5
—
—
—
0
0
9
22
4.11
2.88
2.4
2.5
—
—
—
0
0
709
6417
1.18
2.83
4.1
4.3
—
—
—
0
0
9
23
3.93
2.77
2.4
2.5
—
—
—
0
0
93
663
1.43
2.67
2.0
2.0
—
—
—
0
0
7
202
0.34
2.65
2.1
1.6
40.97
18.36
ug/l
—
7
197
37
617
0.59
2.63
1.8
1.8
—
—
—
0
0
675
6153
1.16
2.35
2.5
2.4
—
—
—
0
0
369
3205
1.19
2.32
2.9
2.7
4.34
4.73
e6/l
0.36
329
2831
11
261
0.42
2.31
1.5
1.5
35.28
31.73
g/l
0.48
11
233
202
1654
1.25
2.28
4.5
7.1
95.61
95.23
%
0.45
195
1595
19
94
2.03
2.16
1.3
1.5
—
—
—
0
0
221
1840
1.23
2.15
4.1
4.8
34.30
33.02
%
1.00
141
1196
19
95
2.01
2.11
1.3
1.5
—
—
—
0
0
126
983
1.30
2.10
3.2
3.8
2.31
2.02
mmol/l
0.38
98
744
1322
13682
0.85
2.09
22.2
20.1
139.87
139.61
mmol/l
3.53
1289
13283
1325
13710
0.85
2.08
22.3
20.2
3.96
4.00
mmol/l
7.71
1294
13289
113
1434
0.77
1.91
3.6
3.0
199.52
244.66
ng/l
0.55
101
1315
17
319
0.53
1.90
1.1
1.2
1.98
6.68
u/ml
—
6
47
130
1036
1.28
1.87
3.3
3.9
5.35
5.17
kpa
1.53
118
961
30
478
0.62
1.85
1.3
1.6
—
143.33
—
0
24
10
219
0.45
1.77
1.0
1.2
—
41.85
—
0
19
22
374
0.58
1.77
1.4
1.6
1.36
17.74
iu/ml
—
8
76
427
3840
1.15
1.71
2.5
2.2
3.13
3.10
mg/l
0.09
335
3234
0
47
0.00
1.70
0.0
2.7
—
3507.91
—
0
11
153
1845
0.81
1.69
3.0
4.0
242.14
248.88
u/l
0.24
132
1744
114
1418
0.79
1.67
3.8
6.9
9.67
10.94
mmol/l
1.34
107
1339
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
44
627
0.69
1.62
1.2
1.2
34.48
137.55
iu/ml
6.11
20
218
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
11
222
0.49
1.58
1.1
1.1
—
—
—
0
0
0
42
0.00
1.52
0.0
1.3
—
9.27
—
0
42
534
4910
1.13
1.51
3.0
3.2
1105.01
1780.45
ng/l
5.21
451
4226
255
2905
0.86
1.51
4.0
4.1
38.60
392.72
ng/l
10.72
203
2469
134
1103
1.23
1.51
1.9
1.6
—
—
—
0
0
14
72
1.95
1.49
1.4
1.4
—
—
—
0
0
14
72
1.95
1.49
1.4
1.4
—
—
—
0
0
209
1799
1.18
1.48
1.8
1.8
—
—
—
0
0
531
4887
1.13
1.48
2.5
3.4
2.34
2.35
mmol/l
0.37
439
4168
21
341
0.61
1.45
1.4
1.5
—
—
—
0
0
52
378
1.39
1.45
1.9
1.7
11147.08
17085.24
e6/l
0.70
39
267
550
5077
1.12
1.45
4.4
3.9
132.44
129.78
e6/l
0.03
406
3784
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
587
0.71
1.42
3.0
2.5
0.46
0.35
u/ml
0.55
24
334
174
2033
0.84
1.41
3.3
5.5
0.99
1.03
mmol/l
1.10
155
1866
56
417
1.35
1.37
1.6
1.6
—
—
—
0
0
177
1514
1.19
1.36
5.0
7.5
121.75
121.01
g/l
0.20
170
1458
5
124
0.40
1.36
1.0
1.2
—
—
—
0
0
11
209
0.52
1.35
1.6
2.5
—
463.56
—
0
16
194
2237
0.85
1.35
23.3
29.1
1.49
1.40
inr
0.19
16
302
131
1564
0.82
1.34
2.1
2.7
9.50
9.34
umol/l
0.02
113
1367
16
271
0.59
1.33
1.1
1.3
—
—
—
0
0
117
1407
0.82
1.30
1.8
2.1
0.20
0.20
g/l
0.47
110
1306
26
390
0.66
1.29
2.3
2.4
13.00
96.72
ug/min
3.18
12
228
11
204
0.54
1.26
1.1
1.2
—
—
—
0
0
171
1470
1.18
1.26
2.3
2.5
5.06
6.94
ug/l
1.57
116
1277
39
538
0.72
1.25
1.3
1.8
39.08
38.20
u/l
0.09
32
468
450
4142
1.12
1.23
3.8
3.4
0.41
0.49
e6/l
0.51
355
3222
341
3754
0.89
1.23
2.2
2.9
6372.67
7042.93
umol/l
0.10
280
3181
43
313
1.38
1.23
2.2
1.6
—
—
—
0
0
10
189
0.53
1.22
1.2
1.2
199.20
291.05
u/ml
—
5
102
25
164
1.53
1.20
2.8
2.6
—
—
—
0
0
26
382
0.68
1.19
1.3
1.7
—
—
—
0
0
13
72
1.81
1.15
1.3
1.3
—
—
—
0
0
29
413
0.70
1.13
2.9
3.1
0.93
0.85
nmol/l
0.28
18
322
24
353
0.68
1.11
1.3
1.2
—
—
—
0
0
204
1801
1.15
1.09
1.8
1.8
—
—
—
0
0
171
1954
0.86
1.08
1.3
1.2
25.27
38.52
iu/ml
1.26
40
623
573
5376
1.10
1.08
2.2
2.2
73.89
78.75
nmol/l
4.34
480
4668
317
2886
1.12
1.06
2.6
3.1
2.45
2.46
mmol/l
0.96
269
2521
165
1885
0.86
1.05
1.3
1.2
5.47
14.22
u/ml
2.09
59
663
316
3460
0.89
1.05
2.9
3.3
0.67
0.79
ug/l
3.47
234
2447
675
6392
1.09
1.03
3.6
4.8
35.11
34.64
g/l
1.37
610
5903
183
1615
1.15
1.00
5.0
3.7
—
—
—
0
0
44
335
1.32
0.99
1.6
2.3
122.92
127.98
g/l
0.60
36
249
29
206
1.41
0.99
1.7
2.4
23.17
23.53
mg/l
—
6
51
7
134
0.52
0.98
1.1
1.3
16.14
12.85
u/l
—
7
123
7
36
1.95
0.97
1.1
1.3
—
—
—
0
0
215
1924
1.13
0.96
1.9
2.5
1.58
1.82
%
3.53
184
1683
564
5315
1.09
0.95
2.9
2.8
139.18
156.22
ug/l
0.89
485
4779
20
291
0.68
0.91
1.1
1.3
—
365.00
—
0
8
19
279
0.68
0.91
1.3
1.4
0.78
0.82
nmol/l
0.09
13
223
18
267
0.67
0.91
1.1
1.1
—
—
—
0
0
9
156
0.57
0.88
1.0
1.1
—
15.83
—
0
7
6
30
2.00
0.87
1.5
1.1
—
—
—
0
0
18
263
0.68
0.85
1.1
1.8
—
—
—
0
0
25
344
0.72
0.85
1.2
1.7
—
—
—
0
0
95
1109
0.85
0.83
3.0
3.0
73.77
61.22
ml/min/173m2
2.19
39
482
378
3522
1.09
0.82
3.8
4.0
85.98
84.78
%
0.44
372
3433
478
4506
1.08
0.80
3.9
3.5
24.71
93.47
e6/l
4.26
382
3562
0
25
0.00
0.79
0.0
1.1
—
18.06
—
0
18
194
2145
0.89
0.79
1.4
1.5
2.22
2.75
g/l
4.13
93
1223
37
286
1.30
0.79
1.4
1.3
1.46
40.84
e6/l
1.19
28
223
37
286
1.30
0.79
1.5
1.3
294.13
678.23
e6/l
0.44
31
231
458
4854
0.92
0.77
4.2
4.7
21.10
21.57
%
0.32
245
2562
139
1230
1.14
0.77
3.1
4.1
1.23
1.22
mmol/l
0.39
120
1055
10
162
0.62
0.77
1.2
1.7
—
—
—
0
0
20
140
1.43
0.77
1.5
1.3
—
—
—
0
0
11
67
1.65
0.75
1.3
1.1
—
—
—
0
0
575
6032
0.93
0.74
4.7
5.4
2.18
4.01
ug/l
1.85
502
5316
60
497
1.21
0.73
1.3
1.3
—
—
—
0
0
161
1445
1.13
0.73
2.1
2.5
59.34
69.16
e9/l
4.29
130
1114
278
2571
1.10
0.72
3.3
2.9
1.97
1.06
e6/l
0.87
164
1535
18
126
1.43
0.70
1.4
1.5
—
—
—
0
0
735
7630
0.94
0.69
6.8
8.9
4.24
4.25
e9/l
0.02
633
6632
11
69
1.60
0.68
1.1
1.4
0.90
0.96
g/l
0.33
11
69
983
9556
1.07
0.68
3.8
3.8
15.37
15.05
pmol/l
3.29
855
8457
11
168
0.65
0.67
1.0
1.0
—
—
—
0
0
14
203
0.69
0.67
1.4
1.5
—
—
—
0
0
14
94
1.49
0.66
1.2
1.5
—
—
—
0
0
51
421
1.22
0.66
1.5
1.4
—
—
—
0
0
1266
12890
0.93
0.64
19.7
17.0
26.96
26.83
mg/l
0.04
1070
10465
8
127
0.63
0.64
1.4
2.1
3.01
4.59
mg/l
—
8
122
8
131
0.61
0.63
1.9
1.4
10.50
13.80
u/l
—
8
123
755
7811
0.94
0.63
2.9
3.2
45.55
55.98
u/l
1.25
669
7097
10
153
0.65
0.62
1.1
1.8
—
—
—
0
0
28
358
0.78
0.62
1.2
1.7
—
—
—
0
0
10
152
0.66
0.61
1.2
1.1
—
—
—
0
0
8
51
1.57
0.60
1.6
1.8
3.96
8.54
nmol/l
—
8
42
19
255
0.74
0.60
1.4
1.3
—
—
—
0
0
21
157
1.34
0.59
1.5
1.3
0.98
0.40
nmol/l
1.44
13
11
19
254
0.75
0.59
1.4
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
24.50
—
0
14
7
112
0.62
0.58
1.6
1.7
—
—
—
0
0
129
1163
1.12
0.57
1.7
2.2
378.79
368.46
nmol/l
0.25
110
1044
82
719
1.15
0.56
1.9
1.9
1.17
1.88
ug/l
0.64
65
624
59
504
1.18
0.56
2.3
2.3
38.85
37.05
g/l
1.64
48
434
17
227
0.75
0.53
1.4
1.4
—
—
—
0
0
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
24
188
1.28
0.51
1.9
7.2
7.38
7.62
mmol/l
0.15
19
159
83
737
1.13
0.49
1.9
2.5
0.67
0.66
%
0.12
76
709
62
541
1.15
0.47
2.2
2.6
0.11
1.46
g/l
7.20
50
467
16
211
0.76
0.47
1.1
1.7
—
—
—
0
0
149
1371
1.10
0.47
1.9
2.7
66.04
66.30
g/l
0.16
119
1247
12
85
1.41
0.47
1.6
1.4
—
—
—
0
0
12
85
1.41
0.47
1.6
1.4
—
—
—
0
0
50
579
0.86
0.46
3.1
2.7
—
—
—
0
0
21
265
0.79
0.45
3.0
4.0
5.62
1.32
%
0.80
16
208
12
164
0.73
0.45
1.3
1.8
—
—
—
0
0
35
293
1.20
0.44
1.5
1.4
—
—
—
0
0
16
207
0.77
0.42
1.5
1.5
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
4.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
2.5
—
0.67
—
0
11
21
260
0.81
0.40
1.4
1.8
8.70
5.14
iu/l
—
7
83
0
18
0.00
0.40
0.0
9.3
—
6.06
—
0
18
106
971
1.10
0.39
1.4
2.2
12.63
12.55
nmol/l
0.03
92
840
599
6164
0.96
0.38
5.4
5.8
60.38
58.36
%
3.79
543
5712
13
170
0.76
0.38
6.6
3.9
—
—
—
0
0
611
6283
0.96
0.37
5.6
6.0
24.79
26.24
%
2.60
549
5791
24
197
1.22
0.37
1.3
1.4
—
—
—
0
0
29
344
0.84
0.37
2.8
3.4
434.42
1137.24
u/ml
0.42
29
320
212
2003
1.07
0.37
4.4
6.5
105.19
104.26
mmol/l
1.97
207
1948
22
268
0.82
0.37
2.4
3.4
59.09
60.11
%
0.17
22
268
38
327
1.17
0.37
1.6
1.6
—
—
—
0
0
8
113
0.71
0.37
1.3
1.1
89.88
95.63
%
—
8
108
35
407
0.86
0.36
1.2
1.2
0.24
0.91
u/ml
—
5
37
37
428
0.86
0.36
2.5
3.6
26.38
25.25
mmol/l
1.32
37
373
9
71
1.27
0.36
1.7
2.3
—
—
—
0
0
5
77
0.65
0.35
1.6
1.4
0.60
3.00
u/field
—
5
54
453
4380
1.05
0.35
2.3
2.5
53.67
57.57
u/l
0.97
409
4001
6
43
1.40
0.35
1.8
1.7
29.22
212.29
ug/l
—
6
36
47
415
1.14
0.34
1.4
1.5
290.81
272.57
ug/g
0.26
31
251
65
587
1.11
0.33
2.2
2.5
2.95
3.14
g/l
0.68
49
468
6
89
0.67
0.33
1.2
1.2
—
—
—
0
0
37
322
1.15
0.32
1.8
2.7
25.41
34.04
umol/l
2.85
32
267
145
1361
1.07
0.32
4.0
6.5
1.23
1.42
mmol/l
1.44
137
1309
21
174
1.21
0.31
1.4
1.5
—
—
—
0
0
21
174
1.21
0.31
1.4
1.5
—
—
—
0
0
7
97
0.72
0.31
1.0
1.1
—
—
—
0
0
7
53
1.32
0.31
1.4
1.0
—
—
—
0
0
28
325
0.86
0.30
1.4
1.6
1.91
4.58
mg/l
0.90
21
250
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
75
1.34
0.30
1.4
1.2
—
—
—
0
0
21
176
1.20
0.29
1.4
1.5
—
—
—
0
0
21
176
1.20
0.29
1.4
1.5
—
—
—
0
0
37
326
1.14
0.29
1.8
2.7
16.19
15.80
%
0.22
22
165
70
642
1.09
0.28
2.4
3.4
4.40
4.34
pmol/l
0.26
63
558
11
140
0.78
0.28
1.0
1.1
—
—
—
0
0
41
459
0.89
0.27
1.0
1.0
—
—
—
0
0
21
177
1.19
0.27
1.4
1.5
—
—
—
0
0
9
116
0.77
0.27
1.1
1.1
—
53.10
—
0
10
114
1214
0.93
0.27
1.2
1.4
—
—
—
0
0
90
837
1.08
0.27
4.7
8.8
25.27
24.32
mmol/l
1.93
83
775
22
257
0.85
0.26
2.2
3.2
4.06
4.51
e9/l
0.65
22
257
130
1228
1.06
0.26
2.4
2.8
4.39
4.49
kpa
0.29
125
1185
31
351
0.88
0.25
7.9
6.5
106.38
105.42
mmol/l
0.59
26
317
246
2370
1.04
0.24
1.2
1.2
1.35
1.59
u/ml
0.19
65
582
16
133
1.20
0.24
2.3
2.0
3.60
2.13
u/field
—
5
46
65
601
1.08
0.23
2.2
2.5
9.26
10.52
g/l
2.53
52
509
244
2357
1.04
0.22
2.2
2.0
30.03
30.03
s
0.01
236
2281
11
135
0.81
0.22
1.2
1.1
—
—
—
0
0
11
135
0.81
0.22
1.1
1.7
—
—
—
0
0
11
135
0.81
0.22
1.1
1.7
—
—
—
0
0
11
135
0.81
0.22
1.1
1.7
—
—
—
0
0
10
124
0.81
0.21
1.2
1.1
—
—
—
0
0
68
633
1.08
0.21
2.2
2.4
3.61
3.85
g/l
0.91
50
461
5
42
1.19
0.21
1.0
1.0
93.80
98.50
%
—
5
34
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
33
367
0.90
0.21
2.2
3.2
8.05
7.77
kpa
0.70
33
335
0
12
0.00
0.21
0.0
1.0
—
25.07
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
12
98
1.23
0.21
1.2
1.3
—
—
—
0
0
68
634
1.08
0.21
2.2
2.4
—
—
—
0
0
68
634
1.08
0.21
2.2
2.4
6.73
7.46
g/l
3.55
49
476
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
142
1485
0.95
0.20
2.6
3.5
2.82
2.04
mmol/l
1.76
110
1173
19
164
1.16
0.20
1.4
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
0.11
—
0
7
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
6
51
1.18
0.19
1.5
1.3
—
—
—
0
0
10
122
0.82
0.19
1.2
1.7
—
—
—
0
0
6
52
1.15
0.19
1.2
1.1
—
1.06
—
0
16
248
2406
1.04
0.19
3.7
3.1
2.40
1.90
e6/l
0.43
133
1377
123
1287
0.95
0.19
2.3
2.3
60.69
38.25
u/l
0.35
101
1096
20
175
1.14
0.18
1.5
1.5
—
—
—
0
0
15
174
0.86
0.17
3.6
3.8
64.00
55.24
%
—
10
117
19
215
0.88
0.16
1.1
1.1
—
—
—
0
0
37
341
1.09
0.16
3.5
3.8
35.27
28.53
mg/l
0.31
21
215
6
77
0.78
0.15
2.8
3.9
—
—
—
0
0
6
79
0.76
0.15
1.0
1.9
—
—
—
0
0
6
80
0.75
0.15
1.2
1.8
—
—
—
0
0
6
80
0.75
0.15
1.2
1.8
—
—
—
0
0
6
80
0.75
0.15
1.2
1.8
—
—
—
0
0
6
80
0.75
0.15
1.2
1.8
—
—
—
0
0
39
361
1.08
0.15
1.2
1.2
—
—
—
0
0
15
132
1.14
0.13
1.1
1.3
—
—
—
0
0
39
364
1.07
0.13
1.2
1.2
—
—
—
0
0
112
1161
0.96
0.13
2.5
3.8
70.17
96.33
ng/l
4.66
80
992
9
110
0.82
0.13
1.2
1.0
—
—
—
0
0
18
161
1.12
0.13
1.2
1.4
—
—
—
0
0
145
1493
0.97
0.12
2.6
3.5
5.84
5.84
kpa
0.00
139
1446
35
374
0.93
0.11
1.6
1.4
—
—
—
0
0
13
147
0.88
0.11
1.2
1.1
115.00
114.99
%
0.00
13
136
15
134
1.12
0.11
1.3
1.2
64.83
55.10
u/l
—
6
94
126
1224
1.03
0.11
1.9
2.1
188.14
160.34
ug/g
0.39
98
957
977
9831
0.99
0.10
3.9
4.2
12.25
14.10
mm/h
3.64
871
8966
6
55
1.09
0.09
1.8
2.7
—
—
—
0
0
6
55
1.09
0.09
1.8
2.7
—
—
—
0
0
6
55
1.09
0.09
1.3
1.2
—
65.71
%
—
0
7
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
1175
11706
1.01
0.07
4.7
4.7
1.94
2.12
mu/l
0.97
1031
10428
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
7
85
0.82
0.07
1.6
1.6
—
—
—
0
0
7
85
0.82
0.07
1.6
1.6
—
—
—
0
0
28
265
1.06
0.07
1.4
1.7
—
—
—
0
0
9
88
1.02
0.07
1.9
3.9
—
—
—
0
0
68
660
1.03
0.06
5.4
4.8
1.51
1.60
%
0.36
62
622
9
104
0.86
0.06
1.4
1.5
—
—
—
0
0
222
2195
1.01
0.05
2.1
2.6
2.31
2.26
g/l
0.51
190
2020
738
7409
0.99
0.04
3.8
6.3
11.50
12.01
umol/l
0.55
685
7004
62
633
0.98
0.03
1.4
1.2
202.44
203.55
u/ml
0.01
56
572
13
139
0.93
0.03
1.2
1.4
196.75
243.85
pmol/l
—
8
108
55
561
0.98
0.03
1.9
3.5
23.36
84.46
mg/l
1.75
47
463
240
2415
0.99
0.02
2.5
3.1
0.83
0.82
mmol/l
1.02
220
2250
72
731
0.98
0.02
2.1
3.7
24.94
24.14
mmol/l
1.04
59
653
55
560
0.98
0.02
1.9
3.5
48.42
64.59
mg/l
0.53
47
460
239
2376
1.01
0.02
2.2
2.6
11.77
12.32
umol/l
0.56
209
2184
23
222
1.04
0.02
1.5
1.3
—
—
—
0
0
207
2082
0.99
0.02
2.2
2.6
21.55
22.19
%
0.24
172
1771
43
438
0.98
0.01
2.1
1.7
—
—
—
0
0
1060
10591
1.00
0.01
5.6
7.8
79.87
80.34
u/l
0.14
967
9879
79
797
0.99
0.01
1.6
1.8
1.63
1.54
g/l
0.38
63
682
34
334
1.02
0.00
1.4
1.4
—
—
—
0
0
34
334
1.02
0.00
1.4
1.4
—
—
—
0
0
48
485
0.99
0.00
1.2
1.2
—
—
—
0
0
26
258
1.01
0.00
1.8
2.1
1.85
1.68
mmol/l
0.27
26
252
41
407
1.01
0.00
1.6
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
10.4
—
—
—
0
0
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
0.00
3.5
3.4
325.67
218.07
u/l
—
6
69
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
24
240
1.00
0.00
1.2
1.4
—
—
—
0
0
6
63
0.95
0.00
1.3
2.0
—
—
—
0
0
6
62
0.97
0.00
1.2
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
8.0
—
74.80
—
0
5
6
62
0.97
0.00
1.2
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.66
—
0
5
0
5
0.00
0.00
0.0
1.0
—
1745.20
—
0
5
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
6
61
0.98
0.00
1.3
2.1
718.00
1560.57
u/ml
—
6
61
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_SELEGILINE – Use of selegiline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).